Fatty Acid Metabolism in Breast Cancer Subtypes
Synapsin Pro LPT Discover the benefits of Synapsin Pro LPT - a premium quality supplement designed to support your health and wellness journey
In late 2025, two Phase 3 trials of semaglutide in early Alzheimers disease missed their primary endpoint, despite years of encouraging epidemiology and biology
Specifically, researchers looked at the rate of discontinuation of the drugs due to adverse events compared to placebo groups and found higher rates of nausea, vomiting and diarrhea
Withdrawal symptoms from semaglutide are an aspect of treatment that health professionals need to consider, ensuring that patients have access to the appropriate support and resources for managing any adverse effects
Endocrine therapy is one piece of care, but for many HR+ cancers, it's a foundational one